Skip Ribbon Commands
Skip to main content
Dr Lee Jie Xin Joycelyn from National Cancer Centre Singapore

Dr Lee Jie Xin Joycelyn

MBBS, MRCP (UK), M Med (Internal Medicine)


Specialty: Medical Oncology

Sub-specialties: Upper Gastrointestinal

Conditions Treated by this Doctor:
Upper Gastrointestinal Cancers.

Clinical Appointments

  • Consultant Division of Medical Oncology National Cancer Centre SingaporeNational Cancer Centre Singapore

Academic Appointments

  • Adjunct Instructor


Dr Joycelyn Lee is a Consultant in the Division of Medical Oncology at National Cancer Centre Singapore. Her interest is in Gastrointestinal cancers.


  • MRCP (UK) 2013 
  • MMed Int Med (S’pore) 2013 
  • MBBS (S’pore) 2011 

Professional Appointments and Committee Memberships

  • Consultant, Division of Medical Oncology, National Cancer Centre Singapore  - present
  • Associate Consultant, Division of Medical Oncology, National Cancer Centre Singapore 2017 - 2019


  • Young Educator Award 2012; Awarded by Singhealth Residency 
  • 1st Mekie Book Prize 2011; Awarded by Yong Loo Lin School of Medicine, NUS 

Research Interests

  • Gastrointestinal cancers 
  • Cancer Cachexia

Publications and Research Trials

  • A review of invasive lobular carcinoma of the breast: Should it be treated like invasive ductal carcinoma? Lee JJX, Lee GE. Integr Cancer Sci Therap 2016; 3(5); doi: 10.15761/ICST.1000211 
  • Clinicopathological characteristics and treatment outcomes in patients with stage I-III invasive Lobular carcinoma of the breast (ILC) treated at the National Cancer Centre Singapore. JJX Lee, Wong FY, J Ngeow et al. J Clin Oncol 34, 2016 (suppl; abstr e12005) 
  • Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor. JJX Lee, A Chan, T Tang. Acta Oncologica 2016; doi: 10.3109/0284186X.2015.1125017 
  • Primary spinal oligoastrocytoma mimicking longitudinally extensive transverse myelitis. TR Yeo, CF Wong, JJX Lee, VZY Ng, K Tan. Multiple Sclerosis and Related Disorders 2015; 3: 590 – 593. 
  • Clinical Development of c-MET inhibition in Hepatocellular Carcinoma. JJX Lee, JJ Chan, SP Choo. Diseases 2015; 3: 306 – 324. 
  • PI3K/Akt/mTOR inhibitors in breast cancer. JJX Lee, K Loh, YS Yap. Cancer Biol Med 2015;12: 342 – 354. 
  • One patient, two uncommon B-cell neoplasms: solitary plasmacytoma following complete remission from intravascular large B-cell lymphoma involving central nervous system. J Lee, SY Tan, LHC Tan, HY Lee, KL Chuah, T Tang, R Quek, K Tay, M Tao, ST Lim, M Farid. Case Reports in Medicine 2014; doi:10.1155/2014/620423 (Article ID 62042)

Research Trials

  • Repurposing Trimetazidine in Cancer Cachexia 2017 - ongoing